From: Quality of life assessment as a predictor of survival in non-small cell lung cancer
QoL Domain | HR | 95% CI | P-value |
---|---|---|---|
Global | 0.991 | 0.989 to 0.994 | < 0.001 |
Gender (male as reference) | 0.78 | 0.68 to 0.91 | 0.001 |
Stage at diagnosis (locoregional disease as reference) | 1.72 | 1.5 to 1.9 | < 0.001 |
Prior treatment history (previously treated as reference) | 0.52 | 0.45 to 0.61 | < 0.001 |